The United Nations Commission on Narcotic Drugs 2020

Drug Science was invited to give expert commentary on: Thematic session 3:The availability of internationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care, remains low to non-existent in many parts of the world; (21 October 2020) After earlier speakers focused on the availability, or lack thereof, of  …


Doctor or drug dealer? International legal provisions for the legitimate handling of drugs of abuse

In this article, we compare how five jurisdictions (the USA; UK; Canada; New Zealand; and Australia) balance the disparate objectives of preventing the misuse of drugs and allowing their legal use for medical purposes. The statutory law underpinning each country‚Äôs method of categorising drugs depicts distinctive outlooks from the different jurisdictions, as each works towards  …


2018: A watershed year for psychedelic science

While interest in the study of psychedelic drugs has increased over much of the last decade, in this article, we argue that 2018 marked the true turning point for the field. Substantive advances in the scientific, public, and regulatory communities in 2018 significantly elevated the status and long-term outlook of psychedelic science, particularly in the  …